ERSTEQ is at the forefront of drug discovery, applying an integrated system using structural analysis and experimental verification to precision develop future drugs for patients and renovate drug discovery
The balance of AI and biology followed by exploitation brought about an explosive improvement in terms of speed and accuracy, which delivers unparalleled progress from initial hits to clinical candidate.
Structural analysis at an atomic level.
Every position of atoms and understanding of their
connections determine the success rate of a discovery.
Only with continual feedback of data from experiments make mode
Decode all relevant experimental data including our own. These data allowed us to build the finest model for analysis and design.
Through our unique approach, we have in-house and joint research pipelines at various development stages across various therapeutic targets.
Our focus is to develop improved therapeutics for treating patients with cancers.
ERSTEQ is committed to the development of innovative medicines for neurodegenerative diseases.